TAYLOR R MYERS

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family OXFORD, OH NPI 1528601044

General Payments — all program years on this page

$2,546.63

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 165
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $638.52 across 38 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $638.5238

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $229.8716
Acerta Pharma LLC $150.297
ABBVIE INC. $78.664
PFIZER INC. $59.703
Exact Sciences Corporation $47.553
GlaxoSmithKline, LLC. $27.652
Lilly USA, LLC $17.211
Otsuka America Pharmaceutical, Inc. $14.221
Amgen Inc. $13.371

By program year

Program yearAmountRecords
2021 $245.9315
2022 $1,275.9289
2023 $386.2623
2024 $638.5238

Records — PY2024 (38)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100235988 Novo Nordisk Inc $15.56 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100241886 Novo Nordisk Inc $18.00 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100306299 Novo Nordisk Inc $16.27 03/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100325144 Novo Nordisk Inc $22.90 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100387797 Novo Nordisk Inc $2.66 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100433913 Novo Nordisk Inc $4.14 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100467598 Novo Nordisk Inc $14.38 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100488079 Novo Nordisk Inc $20.25 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100489977 Novo Nordisk Inc $16.15 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100497539 Novo Nordisk Inc $16.55 01/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100550334 Novo Nordisk Inc $13.52 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100583052 Novo Nordisk Inc $13.01 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100599005 Novo Nordisk Inc $17.11 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100607324 Novo Nordisk Inc $13.12 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100612433 Novo Nordisk Inc $10.06 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100617266 Novo Nordisk Inc $16.19 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104265853 AstraZeneca Pharmaceuticals LP $17.43 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104751622 AstraZeneca Pharmaceuticals LP $18.75 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105454493 AstraZeneca Pharmaceuticals LP $13.85 05/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105617545 AstraZeneca Pharmaceuticals LP $43.40 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105677855 AstraZeneca Pharmaceuticals LP $13.88 01/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105730599 AstraZeneca Pharmaceuticals LP $22.99 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105803295 AstraZeneca Pharmaceuticals LP $19.99 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107715807 ABBVIE INC. $29.38 04/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107715809 ABBVIE INC. $13.52 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107715811 ABBVIE INC. $15.99 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107715813 ABBVIE INC. $19.77 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114547019 Exact Sciences Corporation $14.83 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114547023 Exact Sciences Corporation $16.16 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114547027 Exact Sciences Corporation $16.56 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116518278 GlaxoSmithKline, LLC. $13.65 11/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116625106 GlaxoSmithKline, LLC. $14.00 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117637279 Amgen Inc. $13.37 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119146833 Otsuka America Pharmaceutical, Inc. $14.22 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131241976 PFIZER INC. $15.12 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132020191 PFIZER INC. $20.48 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132032621 PFIZER INC. $24.10 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135978976 Lilly USA, LLC $17.21 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.